If abdominal pain, nausea, or vomiting occurs during drug therapy for Graves' disease, drug-induced pancreatitis should be considered in the differential diagnosis. If pancreatitis develops during treatment with MMI, switching to PTU should be approached with caution due to the potential for cross-reactivity - and vice versa. In the event that MMI or PTU results in adverse effects, alternative therapeutic modalities should be considered, including radioactive iodine (131I) therapy or surgical interventions. These considerations should be informed by the concomitant increase in IgG4 concentration.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yuriko Yamazaki
Junichiro Adachi
Yurika Ishihara
Endocrinology Diabetes and Metabolism Case Reports
Saitama Medical University
Social Insurance Saitama Chuo Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Yamazaki et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d893406c1944d70ce043f0 — DOI: https://doi.org/10.1530/edm-25-0135